When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BIOVF - Dova's Doptelet OK'd in China for low blood platelets in liver disease patients
Swedish Orphan Biovit Ord
The China National Medical Products Administration has approved Dova Pharmaceuticals' Doptelet (avatrombopag) for chronic liver disease patients with thrombocytopenia (low blood platelets) who are undergoing a procedure.
More news on: Swedish Orphan Biovitrum AB (publ), Healthcare stocks news,